John K. Cox
#2,166,144
Most Influential Person
American historian
Why Is John K. Cox Influential?
(Suggest an Edit or Addition)John K. Cox's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. (2000) (2528)
- Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. (2002) (203)
- A multicenter, Phase II trial of weekly irinotecan (CPT‐11) in patients with previously treated colorectal carcinoma (1999) (194)
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. (2008) (186)
- Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. (1988) (142)
- "I know it when I see it". (2009) (78)
- The frequency of anemia and iron deficiency in the runner. (1989) (52)
- Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 1 of 2. (2008) (42)
- Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach. (2016) (34)
- Evaluation of bone marrow iron stores in anemia associated with chronic disease: A comparative study of serum and red cell ferritin (1993) (28)
- Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2. (2008) (26)
- Phase III trial of capecitabine + oxaliplatin (XELOX) vs. 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (FOLFOX4) as 2nd-line treatment for patients with metastatic colorectal cancer (MCRC) (2007) (23)
- Detection and Staging of Small Cell Lung Carcinoma with a Technetium‐labeled Monoclonal Antibody A Comparison with Standard Staging Methods (1992) (19)
- Payment for oncolytics in the United States: a history of buy and bill and proposals for reform. (2014) (18)
- The relative value of conventional staging procedures for developing prognostic models in extensive-stage small-cell lung cancer. (1990) (17)
- Conceptual Model for Accrual to Cancer Clinical Trials. (2019) (17)
- Care coordination for complex cancer survivors in an integrated safety-net system: a study protocol (2018) (16)
- A Pathway Through the Bundle Jungle. (2016) (13)
- The Centers for Medicare & Medicaid Services Oncology Care Model Halfway Through - Perspectives from Diverse Participants. (2019) (12)
- Community oncology in an era of payment reform. (2014) (11)
- Radionuclide Imaging of Bone Marrow Metastases with a Tc‐99m Labeled Monoclonal Antibody to Small Cell Lung Carcinoma (1991) (10)
- Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes. (2020) (10)
- Oncology Medical Home: ASCO and COA Standards. (2021) (8)
- Patient and provider perspectives on delivery of oral cancer therapies. (2019) (8)
- Intentional approach to team-based oncology care: evidence-based teamwork to improve collaboration and patient engagement. (2015) (7)
- Inherited bone marrow failure: the men behind the empty space (1999) (7)
- A randomized trial of mail and email recruitment strategies for a physician survey on clinical trial accrual (2020) (7)
- Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low‐dose cytosine arabinoside (1988) (6)
- Seeking serenity with influence. (2010) (6)
- Effective management of patients receiving XELOX: Evaluation of impact of dose modifications on outcome in patients from the NO16966, NO16967, and NO16968 trials. (2011) (5)
- An eosinophilic fibrohistiocytic lesion of bone marrow in a patient with Hodgkin's disease. A potential for morphologic confusion (1991) (4)
- Data and knowledge. (2011) (4)
- Setting standards, saving lives. (2012) (3)
- Impact on Oncology Practices of Including Drug Costs in Bundled Payments. (2018) (3)
- Provisional clinical opinion. (2009) (3)
- A Phase II study of gemcitabine plus zoledronic acid in subjects with Stage IV pancreatic cancer. (2006) (3)
- An eosinophilic fibrohistiocytic lesion of bone marrow in a patient with Hodgkin's disease. A potential for morphologic confusion. (1991) (3)
- Prior Frequent Emergency Department Use as a Predictor of Emergency Department Visits After a New Cancer Diagnosis. (2021) (3)
- Understanding and surviving the transition to value-based oncology. (2013) (3)
- Patient-centered medical home: renewing primary care. (2008) (3)
- Initial Experience with M-VAC for Metastatic Transitional Cell Carcinoma (TCC) (1987) (3)
- Provisional clinical opinion. (2009) (2)
- Ethical challenges: oncologists' role in immigrant health care. (2010) (2)
- Quantifying the potential of C-11 acetate PET scanning in avanced prostate cancer patients. (2016) (2)
- 3012 ORAL Capecitabine + oxaliplatin (XELOX) vs. 5-FU/LV + oxaliplatin (FOLFOX4) as second-line treatment for patients with metastatic colorectal cancer (MCRC): Phase III trial results (2007) (2)
- ASCO's Commitment to a Better Electronic Health Record-We Need Your Help! (2008) (2)
- Access, quality, and cost. (2009) (2)
- Business and science: lessons from the 2011 cancer center business summit. (2012) (2)
- Policy and politics: a call for papers. (2014) (1)
- Victimized again? (2010) (1)
- The role of experience and clinical decision support in clinical trial accrual within oncology. (2021) (1)
- Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual. (2021) (1)
- Five pieces of silver. (2012) (1)
- A nutrition-focused quality improvement program to improve rate of documented nutrition plan at a safety-net hospital gastrointestinal (GI) oncology clinic. (2019) (1)
- Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital (2021) (1)
- State of oncology practice. (2011) (1)
- States rule. (2011) (0)
- What Our Leaders Are Reading. (2005) (0)
- Integrated analysis of overall survival from two multicenter randomized trials of 5-fluorouracil (5-FU) and leucovorin (LV) with or without trimetrexate (TMTX) in patients with advanced colorectal cancer (ACC) (2001) (0)
- So many issues, so little time. (2010) (0)
- Relationship of emergency department use pre- and post-cancer diagnosis in safety-net adults. (2019) (0)
- Are ED visits in cancer patients preventable? Care patterns before an ED visit. (2020) (0)
- Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors. (2022) (0)
- Working Smarter Toward Quality Care (2005) (0)
- Electronic health records will transform practice. (2011) (0)
- Palliative care and end-of-life health care utilization of pancreatic cancer patients at an urban safety-net hospital. (2018) (0)
- Working Smarter Toward Quality Care. (2005) (0)
- Martyrs for better care. (2012) (0)
- Patient care and economics. (2010) (0)
- Katrina and ASCO: Lessons to be Learned. (2005) (0)
- Prescribing patterns for FOLFIRINOX in the real world. (2018) (0)
- Reprise: Transformation. (2013) (0)
- What Our Leaders Are Reading (2005) (0)
- Colon Cancer Screening (2002) (0)
- Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors. (2022) (0)
- Reply to M. Thompson et Al. (2015) (0)
- Differences in clinical outcomes in young-onset colorectal cancer based on ethnicity in an NCI designated comprehensive cancer center. (2019) (0)
- Mind the Gap. (2006) (0)
- Impact of palliative care consults on racial disparity in do-not resuscitation (DNR) orders at an urban safety net hospital. (2018) (0)
- Health care reform: never mind? (2010) (0)
- From the Editor's Desk Medicare's Seasons (2009) (0)
- Developing dialogue in health care. (2011) (0)
- Reprise: State of Oncology Practice. (2011) (0)
- Toward Team-Based Cancer Care in the United States: 6 Years Later (2022) (0)
- Your Clinical Practice Committee. (2005) (0)
- How Safe Is Cancer Care? (2022) (0)
- Developing dialogue in healthcare. (2011) (0)
- Revolutions. (2011) (0)
- The oncology care model, care delivery & payment reform: a riddle wrapped in risk, culture & opportunity: perspectives of a frustrated, optimistic, liberal, red state oncologist facing High Noon (2016) (0)
- Medicare's Seasons. (2009) (0)
- Phase I I S tudy o f O ral C apecitabine i n P atients W ith Advanced o r M etastatic P ancreatic C ancer (2002) (0)
- "The sands are number'd that make up my life…" Shakespeare. (2006) (0)
- Palliative care: staying alive as long as we live. (2011) (0)
- The Voice of ASCO (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John K. Cox?
John K. Cox is affiliated with the following schools:
